English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Response of unvaccinated US adults to official information about the pause in use of the johnson & johnson janssen covid-19 vaccine: Cross-sectional survey study Journal article
Mishra, Vishala, Dexter, Joseph P.. Response of unvaccinated US adults to official information about the pause in use of the johnson & johnson janssen covid-19 vaccine: Cross-sectional survey study[J]. Journal of Medical Internet Research, 2024, 26(1), e41559.
Authors:  Mishra, Vishala;  Dexter, Joseph P.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:5.8/6.7 | Submit date：2024/05/16
Cdc  Centers For Disease Control And Prevention  Covid-19  Health Communication  Health Information  Health Literacy  Public Health  Risk Perception  Sars-cov-2  Vaccine Hesitancy  Web-based Surveys  
Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery Journal article
Li, Ting, Jiang, Hu-Lin, Tong, Yun-Guang, Lu, Jin-Jian. Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11.
Authors:  Li, Ting;  Jiang, Hu-Lin;  Tong, Yun-Guang;  Lu, Jin-Jian
Favorite | TC[WOS]:42 TC[Scopus]:47  IF:29.5/26.9 | Submit date：2018/10/30
Hsp90 Chaperone Machinery  Cdc37  Kinase Client  Protein Interaction  
Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor Journal article
Li, Ting, Chen, Xin, Dai, Xiao-Yang, Wei, Bin, Weng, Qin-Jie, Chen, Xiuping, Ouyang, De-Fang, Yan, Ru, Huang, Zhang-Jian, Jiang, Hu-Lin, Zhu, Hong, Lu, Jin-Jian. Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 330, 65-73.
Authors:  Li, Ting;  Chen, Xin;  Dai, Xiao-Yang;  Wei, Bin;  Weng, Qin-Jie; et al.
Favorite | TC[WOS]:31 TC[Scopus]:31  IF:3.3/3.6 | Submit date：2018/10/30
Everolimus  Platycodin d  Hsp90  Cdc37  Egfr  Igf1r  
Platycodin D, a novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex, enhances the anti-cancer effect of mTOR inhibitor Conference paper
Li, T, Chen, X, Dai, XY, Wei, B, Weng, QJ, Chen, X. P., Ouyang, D., Yan, R., Huang, ZJ, Jiang, HL, Zhu, H, Lu, J.. Platycodin D, a novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex, enhances the anti-cancer effect of mTOR inhibitor[C], 2017.
Authors:  Li, T;  Chen, X;  Dai, XY;  Wei, B;  Weng, QJ; et al.
Favorite |  | Submit date：2022/08/26
Everolimus  platycodin D  Hsp90  Cdc37  EGFR  IGF1R  
Platycodin D targets Hsp90 activity by disrupting Hsp90/Cdc37 cochaperones interaction Conference paper
Li, T, Wei, B, Chen, X, Chen, X. P., Ouyang, D., Yan, R., Wang, Y. T., Lu, J.. Platycodin D targets Hsp90 activity by disrupting Hsp90/Cdc37 cochaperones interaction[C], 2016.
Authors:  Li, T;  Wei, B;  Chen, X;  Chen, X. P.;  Ouyang, D.; et al.
Favorite |  | Submit date：2022/08/26
Hsp90 inhibitor  platycodin D  Cdc37  cochaperones interaction